Optimizing Investments in Kazakhstan's HIV Response

doi:10.1596/24965

Publication:
Optimizing Investments in Kazakhstan's HIV Response

dc.contributor.author	World Bank
dc.contributor.other	Benedikt, Clemens
dc.contributor.other	Wilson, David
dc.contributor.other	Masaki, Emiko
dc.contributor.other	Görgens, Marelize
dc.contributor.other	Obst, Michael
dc.date.accessioned	2016-08-29T16:46:08Z
dc.date.available	2016-08-29T16:46:08Z
dc.date.issued	2016-03-01
dc.description.abstract	As part of a Regional initiative, Kazakhstan conducted an Human Immunodeficiency Virus (HIV) allocative efficiency analysis in 2014 to 2015 to inform more strategic investment in HIV programs. Kazakhstan continues to experience a concentrated HIV epidemic in which the majority of new infections occurred among key populations, particularly PWID, MSM, prison inmates, FSW, and their clients. Under current conditions (constant behaviors and program coverage), new HIV infections are projected to rise by 13 percent and deaths by 32 percent. The epidemics among PWID and MSM are projected to account for 67 percent of new HIV infections from 2015 to 2020 so need to be a core focus of programs. With optimized allocations, the cost to achieve national targets (no increase in incidence and deaths from 2015 to 2020) would be US 52 million dollars per year. The cost to achieve more ambitious future HIV response targets was estimated at US 80 million dollars.In conclusion, a combination of various efficiency gains in Kazakhstan’s HIV response can halve new HIV infections and deaths, achieving ambitious national targets at no additional cost. As a first priority, ART will be essential for reducing deaths and new infections, but unit costs need to be reviewed and reduced. A second consistent finding is the continued need to provide HIV services for PWID at scale. A third consistent finding is the need to scale up programs for MSM and at least double the current low coverage levels. Additional technical efficiency analysis is worth considering to explore the concrete pathways to achieve the proposed cost reductions for ART, OST, and management costs.	en
dc.identifier	http://documents.worldbank.org/curated/en/2016/07/26570531/optimizing-investments-kazakhstans-hiv-response
dc.identifier.doi	10.1596/24965
dc.identifier.uri	https://hdl.handle.net/10986/24965
dc.language	English
dc.language.iso	en_US
dc.publisher	World Bank, Washington, DC
dc.rights	CC BY 3.0 IGO
dc.rights.holder	World Bank
dc.rights.uri	http://creativecommons.org/licenses/by/3.0/igo/
dc.subject	health financing
dc.subject	HIV
dc.subject	antiretroviral therapy
dc.subject	opioid substitution therapy
dc.subject	health expenditure
dc.subject	aid disbursements
dc.title	Optimizing Investments in Kazakhstan's HIV Response	en
dc.title.alternative	Оценка экологических и социальных последствий для сельских кластеров в рамках этапа 1 в Сохаг	en
dc.type	Working Paper	en
dc.type	Document de travail	fr
dc.type	Documento de trabajo	es
dspace.entity.type	Publication
okr.crossref.title	Optimizing Investments in Kazakhstan's HIV ResponseОценка экологических и социальных последствий для сельских кластеров в рамках этапа 1 в Сохаг
okr.date.disclosure	2016-07-14
okr.doctype	Publications & Research
okr.doctype	Publications & Research::Working Paper
okr.docurl	http://documents.worldbank.org/curated/en/2016/07/26570531/optimizing-investments-kazakhstans-hiv-response
okr.guid	923631468496932840
okr.guid	197261468496125992
okr.identifier.doi	10.1596/24965
okr.identifier.externaldocumentum	090224b087836fd2_3_0
okr.identifier.internaldocumentum	26570531
okr.identifier.report	106814
okr.imported	true
okr.language.supported	en
okr.pdfurl	http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2016/07/14/090224b08445544b/1_0/Rendered/PDF/Optimizing0inv0hstan0s0HIV0response.pdf	en
okr.region.administrative	Europe and Central Asia
okr.region.country	Kazakhstan
okr.topic	Macroeconomics and Economic Growth::Development Economics & Aid Effectiveness
okr.topic	Health, Nutrition and Population::HIV AIDS
okr.topic	Health, Nutrition and Population::Disease Control & Prevention
okr.topic	Health, Nutrition and Population::Health Economics & Finance